Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Health & Baby

Font Size

Reflux Medication Found Safe in Infants Studied

WebMD Health News

Feb. 10, 2000 (Washington) -- Propulsid (cisapride), a drug used to treat reflux, a condition that causes some infants to spit up frequently, did not create heart problems in 100 infants who were given it as part of a study. While the findings signal good news for babies with this disorder, the medication is still under review by the FDA, which has linked it to serious heart rhythm irregularities and deaths.

Reflux results when a band of muscle called the sphincter, which connects the infant's esophagus to the stomach, does not properly close, allowing for food particles to wash back up into the throat. In infants, Propulsid works by moving food more quickly through the stomach and intestines, reducing the chances that it can come back up.

In January, the FDA recommended that all patients on Propulsid, which is approved only for use in adults with heartburn, receive an electrocardiogram (ECG) prior to starting therapy, and that the drug not be given if certain values exceed the normal range. The warning, co-issued with Janssen Pharmaceutica Research Foundation, the manufacturer, repeated the list of certain drugs that, given with Propulsid, could cause heart problems. The FDA also announced it had 270 reported cases of arrhythmias, including 70 fatalities, that occurred in people using the drug. Of the total, 85% of the patients had known risk factors that should have kept them from ever receiving the medication.

In this study, reported in the current issue of Pediatrics, researchers from Tulane University studied 100 infants, aged 3-6 months, who had been diagnosed with reflux. Sixty were given an ECG before being given Propulsid, and 40 were given one after they had been on the medication for 1-4 months. None of the babies experienced arrhythmias, or irregular heartbeats, although more than half had an elevation in what is known as QT intervals. However, only two of the infants had ranges above normal for QT readings, and the values returned to normal after the medication was stopped.

The lead author of the study remains convinced that the medication is safe when used properly.

1 | 2 | 3

Baby's First Year Newsletter

Because every week matters, get expert advice and facts on what to expect in your baby's first year.

Today on WebMD

mother on phone holding baby
When you should call 911.
parents and baby
Unexpected ways your life will change.
baby acne
What’s normal – and what’s not.
baby asleep on moms shoulder
Help your baby get the sleep he needs.

mother holding baby at night
mother with sick child
Chinese mother breast feeding newborn baby girl
Track Your Babys Vaccines
Baby Napping 10 Dos And Donts
Woman holding feet up to camera
Father kissing newborn baby
baby gear slideshow